No significant impact of response to prior androgen receptor-axis-targeted agents on the efficacy of subsequent docetaxel in patients with metastatic castration-resistant prostate cancer
Crossref DOI link: https://doi.org/10.1007/s10147-017-1230-y
Published Online: 2017-12-23
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Miyake, Hideaki
Matsushita, Yuto
Tamura, Keita
Motoyama, Daisuke
Ito, Toshiki
Sugiyama, Takayuki
Otsuka, Atsushi
License valid from 2017-12-23